Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II) - sprookjes - yvandenbroek - TriplyDB

Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)

Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)

http://www.wikidata.org/entity/Q28281495

about

Non-acute percutaneous coronary intervention versus medical therapy in patients with ischaemic heart disease Primary stenting versus primary balloon angioplasty for treating acute myocardial infarction Fortnightly review: Intracoronary stents.Long-term outcome after coronary stenting Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight Recent advances in drug eluting stents Catheter based intracoronary brachytherapy leads to increased platelet activation Acute and 6-month clinical and angiographic outcome after implantation of the ACS Duet stent for single-vessel coronary artery disease: final results of the European and US ACS Multi-link Duet Registry Aspirin alone antiplatelet regimen after intracoronary placement of the Carbostent: the ANTARES study Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology Treatment for stable coronary artery disease: a network meta-analysis of cost-effectiveness studies Intravascular ultrasound-guided stenting in long lesions: an insight into possible mechanisms of restenosis and comparison of angiographic and intravascular ultrasound data from the MUSIC and RENEWAL trials.Initial and follow-up results of the Tenax coronary stent.Angioplasty and stents in coronary artery disease: a systematic review and meta-analysis.Coronary stents: in these days of climate change should all stents wear coats?Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis.New developments in endovascular interventions for extracranial carotid stenosis.Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis.Stent development and local drug delivery.Diffuse in-stent restenosis.Are "treatment" bare metal stents superior to "control" bare metal stents? A meta-analytic approach Coronary artery stents: evaluating new designs for contemporary percutaneous intervention.Validity of Cardiac Markers as Diagnostic and Prognostic Indicators of Complications in Patients undergoing Percutaneous Coronary Intervention Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling.Genetic polymorphism of angiotensin converting enzyme and risk of coronary restenosis after percutaneous transluminal coronary angioplasties: evidence from 33 cohort studies Developments in restenosis.Influence of the angiotensin converting enzyme insertion or deletion genetic variant and coronary restenosis risk: evidence based on 11,193 subjects Targeting the cell cycle machinery for the treatment of cardiovascular disease.Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application.Direct coronary stenting compared with stenting after predilatation is feasible, safe, and more cost-effective in selected patients: evidence to date indicating similar late outcomes.Is provisional stenting the effective option? The WIDEST study (Wiktor stent in de novo stenosis). Widest Trial Investigators' Group Long term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarction Population need for coronary revascularisation: are national targets for England credible?Plaque stabilisation by systemic and local drug administration.One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial Early experiences and clinical implications of restenosis and drug-eluting stents: Part 2.Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials.Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice.Clinical Coronary In-Stent Restenosis Follow-Up after Treatment and Analyses of Clinical Outcomes.

P2860

Q24186673-6B55FD6D-A92A-413D-B5D8-2FD25D0A6485 Q24246929-E2EF2B32-900E-4155-9135-ED4106FC610A Q24524277-D0AA4372-027C-487E-900B-5E8598AB18E8 Q24792495-DA408320-75DD-4844-92EB-DF8B399B7543 Q24793199-D92AB756-B3DA-4E46-BE04-A781201DC5B5 Q24799198-7E1F4ABD-73AB-4782-AE05-8DAF518EF154 Q27025538-7070AB70-AC36-4842-A7A7-FECEE7CC9977 Q28166830-A698FB4D-7414-494C-BF58-FCD78960935F Q28189014-5E60042B-5C2F-4DA0-B24C-9CEFE966B663 Q28192340-E381BE75-0D82-4BDA-94BC-D7B5253AECB3 Q28239975-D9C537A2-3763-4C77-8BFB-DEEBA8AF9F6B Q28539350-F1C2C1BC-0DAD-48B4-8D70-C81356EF675B Q30330430-A0D10BF4-0114-4EBD-A8E6-7A87D4B00E30 Q30735573-4D7C96D5-5A16-4B1D-B7F4-270E79415BAA Q33209136-A21A8158-DEAA-48F5-B83D-FFB50A0626D8 Q33215919-E7D51BBA-B38D-436D-8870-EE7F700759BE Q33791885-AC0E963A-1983-457A-AF8A-9B9BECF1454B Q34091045-568E9A6D-92DC-4662-BA15-3521C448DE6F Q34256787-E94DC082-8688-4F2A-94F8-F632287D019F Q34470332-37A856DF-16E3-4379-954E-2EFC1D9FC9AC Q34675116-D0337320-ED92-400A-BA90-26858C531A6F Q34731151-0BC6246B-8AF6-4CBA-ACC5-B8C64749509A Q34747489-9BE96FB4-AD84-4B1F-87F6-00332A8C649D Q34782266-2414DD89-4FE7-437C-8A77-20A2F2706221 Q35001659-12DECDBA-0E1D-419D-9998-7B2C93953BC7 Q35009992-D5F6A2AA-BAE6-4677-81BD-F6DF5DB6561C Q35058624-FA3857E4-449A-4A08-B3D5-DEC9D9C742A4 Q35070955-1A0A20E7-9CEC-46F8-BC7E-766F2D581957 Q35164884-768FC04A-54F8-4C29-AD03-9E14E4D51DF4 Q35205423-997C8462-DC4A-43C5-94C2-DE8D763E1488 Q35213597-8ACFACB2-55DF-4E52-9114-9872537C7F42 Q35376903-BD7A8AB6-B8D1-4870-A86E-34326CC405AA Q35379601-930BA357-0133-48C2-9C3E-CBF082734841 Q35580599-6ED5922D-25F1-42E1-8637-32B92564D113 Q35583277-B27E19CC-7948-4155-B764-2956E971869F Q35584009-D228721B-89D8-42FF-A404-22ED1610AD11 Q35708574-F6D3C915-8EF8-4BB3-8150-B194AEC52D24 Q35771807-990E2E5B-9495-4600-AD7A-75726669D853 Q35829683-D2AF92CB-5191-461B-911B-FA03A9D5BADC Q35830197-5026E60E-0229-42B4-A2B2-F6EF049EE978

P2860

Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)

http://www.wikidata.org/entity/Q28281495

description

1998 nî lūn-bûn

@nan

1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Randomised comparison of impla ...... artery disease (Benestent II)

@ast

Randomised comparison of impla ...... artery disease (Benestent II)

@en

Randomised comparison of impla ...... artery disease (Benestent II)

@nl

type

label

Randomised comparison of impla ...... artery disease (Benestent II)

@ast

Randomised comparison of impla ...... artery disease (Benestent II)

@en

Randomised comparison of impla ...... artery disease (Benestent II)

@nl

prefLabel

Randomised comparison of impla ...... artery disease (Benestent II)

@ast

Randomised comparison of impla ...... artery disease (Benestent II)

@en

Randomised comparison of impla ...... artery disease (Benestent II)

@nl

P1433

Q28281495-1F3A8646-9930-424E-988A-9FFE867C17B1

P1476

Q28281495-35214D8F-619C-4249-8307-D1403EF7A9E6

P2093

Q28281495-05B4A5A7-1400-48C4-A680-262BDB047CFF

Q28281495-1F0B1366-F1AD-4DE0-8492-0F00B124151F

Q28281495-2E2029C3-E214-443C-9529-28EE82DA3BA8

Q28281495-3C652FA4-78D7-4F97-B078-6A06C68E9AE7

Q28281495-576269BC-53DE-4DB0-872E-55776CEF93E0

Q28281495-5B70D241-BD3F-46EA-9780-E935AAC9F40B

Q28281495-7671714E-0A19-4D53-B423-A2E1427933C0

Q28281495-7CFE1094-1D7F-4C3E-A77F-E3C771558C4B

Q28281495-909F22DA-C870-4F43-A670-87B0E21B3F7C

Q28281495-9C6C0A4D-46A3-414B-A502-E39995659127

P304

Q28281495-3FBDCA3C-E416-49DD-9673-81A6C0211057

P31

Q28281495-E9E2B9F4-5F82-49CC-82F7-B25B865C0C47

P356

Q28281495-72AF5DCB-3270-4C87-AC5D-34FDBFE91CC1

P407

Q28281495-1337F10B-09F2-4A11-9B9F-D649074559EF

P433

Q28281495-DB557D75-CA06-4D1F-B188-F24CE808046C

P478

Q28281495-67276068-3987-49FF-A804-F7A05A976D00

P50

Q28281495-98511F7B-3F31-4705-A5C3-B3A0CDA65BDE

P577

Q28281495-AB2CA49E-4AA8-4642-BD69-E35A0C761F6C

P698

Q28281495-6AA829CD-A701-464D-A281-1EB99B9E447F

P356

S0140-6736(97)11128-X

P1433

P1476

Randomised comparison of impla ...... artery disease (Benestent II)

@en

P2093

A Colombo

http://www.w3.org/2001/XMLSchema#string

B van Hout

http://www.w3.org/2001/XMLSchema#string

C Macaya

http://www.w3.org/2001/XMLSchema#string

E Garcia

http://www.w3.org/2001/XMLSchema#string

E Sousa

http://www.w3.org/2001/XMLSchema#string

F Kiemeneij

http://www.w3.org/2001/XMLSchema#string

H Bonnier

http://www.w3.org/2001/XMLSchema#string

J Fajadet

http://www.w3.org/2001/XMLSchema#string

J Ormiston

http://www.w3.org/2001/XMLSchema#string

M A Morel

http://www.w3.org/2001/XMLSchema#string

P304

673-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0140-6736(97)11128-X

http://www.w3.org/2001/XMLSchema#string

P407

P433

9129

http://www.w3.org/2001/XMLSchema#string

P478

352

http://www.w3.org/2001/XMLSchema#string

P50

Håkan Emanuelsson

P577

1998-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9728982

http://www.w3.org/2001/XMLSchema#string